Opportunity
NIH Reporter #PA-23-262
NIH Research Grant: Biomarkers of Ischemic Risk in Sickle Cell Disease
Posted
July 20, 2026
Identifier
PA-23-262
NAICS
541715, 541714
This opportunity is a research grant solicitation from the National Institutes of Health (NIH) focused on biomarkers of ischemic risk in adults with sickle cell disease. - Government Buyer: - National Institutes of Health (NIH) - Project to be conducted at Vanderbilt University Medical Center, Nashville, TN - Products/Services Requested: - Research and data analysis on biomarkers of ischemic risk in adults with sickle cell disease - Focus on cerebral oxygen utilization using non-invasive imaging techniques - Expertise required in non-invasive imaging and analysis of biomarkers related to stroke risk - OEMs and Vendors: - No specific OEMs or commercial vendors are named, as this is a research grant - Unique/Notable Requirements: - Emphasis on non-invasive imaging technology - Research must address stroke risk in sickle cell disease population - Applicants must demonstrate relevant expertise in the specified research area
Description
This NIH grant opportunity focuses on research related to biomarkers associated with ischemic risk in adults with sickle cell disease. The project aims to investigate cerebral oxygen utilization using non-invasive imaging techniques. The scope includes research and data analysis to better understand stroke risk in this patient population. The work will be conducted at Vanderbilt University Medical Center in Nashville, TN.